
Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-265-1700
Fax+1 608-262-1982
Are you Dr. Wilding?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. George Wilding, MD is an oncologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Texas. He is a "Vice Provost of Clinical and Interdisciplinary Research at The University.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1983 - 1986
- UMass Chan Medical SchoolResidency, Internal Medicine, 1980 - 1983
- University of Massachusetts Medical SchoolClass of 1980
Certifications & Licensure
- TX State Medical License 2018 - 2025
- WI State Medical License 1988 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsOverall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma.Robert J Motzer, Thomas E Hutson, Piotr Tomczak, M Dror Michaelson, Ronald M Bukowski
Journal of Clinical Oncology. 2023-04-10 - 6 citationsPredicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool.Savitri Krishnamurthy, Parag Jain, Debu Tripathy, Roland Basset, Ramandeep Randhawa
JCO Clinical Cancer Informatics. 2023-03-01 - 13 citationsA Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers.Wei Huang, Ramandeep Randhawa, Parag Jain, Samuel Hubbard, Jens Eickhoff
JCO Clinical Cancer Informatics. 2022-02-01
Press Mentions
- How Unexpected Results Can Lead Cancer Research and Treatment in New DirectionsJanuary 7th, 2019
- Intermittent Androgen Deprivation Not Equivalent to Continuous Treatment for Prostate Cancer, May Compromise SurvivalApril 5th, 2013